mRNA / Vaccine Technologist
mRNA and vaccine technologists work in vaccine manufacturing and quality control — formulation, cold-chain-sensitive production processes, and regulatory-compliant quality assurance testing. This role sits at the leading edge of Africa's push toward vaccine manufacturing self-sufficiency following the supply disruptions experienced during COVID-19.
Africa CDC's continental vaccine manufacturing initiative includes emerging capacity investment, and while large-scale mRNA production remains concentrated in a handful of facilities, Kenya's biotech and pharmaceutical sector is building relevant capability and talent.
- AI exposure
- 28 of 100, low exposure
- Hiring trend
- Growing
- Hiring rate
- 24%
- Minimum education
- Bachelor
The role
What the work is, what it pays, and what it costs you.
At a glance
- Remote friendly
- No
- Freelance potential
- Low
- Freelance rate
- Ksh 4,000
- Time to senior
- 6 years
A day in the role
"Every step is documented and double-checked — vaccine production has almost no tolerance for the kind of small errors that might be forgivable in other manufacturing contexts."
What it pays
Kenyan market, per month- Entry
- KES 90,000–150,000
- Mid
- KES 170,000–280,000
- Senior
- KES 300,000–480,000
The trade offs
In its favour
- High-impact work supporting African health security and vaccine self-sufficiency.
- Positions technologists at the frontier of Africa's growing biomanufacturing sector.
Against it
- Small current job market concentrated at a handful of facilities.
- Highly regulated work with strict, sometimes rigid protocols.
In practice
Pursue biotechnology or pharmacy training with a focus on GMP quality systems, and seek entry roles or internships with pharmaceutical manufacturers or research institutions like KEMRI.
Progression runs production/QC technician → vaccine technologist → production manager/quality assurance lead, as African manufacturing capacity expands.
KEMRI and emerging African vaccine manufacturing facilities are the primary current employers, with growth tied to continental capacity investment.
A typical day includes production process monitoring, quality control testing, and rigorous documentation per regulatory standards.
Exposure
How much of this a machine can already do, and how that was worked out.
Where this rating sits
1,516 rated careersRated above 24% of the 1,516 careers in the catalogue, which averages 43. Inside health sciences the mean is 25, across 137 careers.
What the rating is made of
Share of recorded tasks- Machine does it
- 20%Software can already complete this work end to end.
- Machine assists
- 40%A person still decides, but the drafting is done for them.
- Person does it
- 40%Judgement, relationships and accountability that do not transfer.
Named task by task
Already automated
- Monitoring production process quality data
- Generating batch documentation
Still human
- Operating and monitoring vaccine formulation/production processes
- Conducting quality control and assurance testing per regulatory standards
- Managing cold-chain-sensitive material handling
- Documenting production batches for regulatory compliance
Task counts
- Tasks recorded
- 7
- Automatable now
- 1
- Still human
- 5
- Augmenting
- Process quality monitoring,Batch documentation
- Creating
- African vaccine manufacturing capacity roles
Sources
Behind the rating- Africa CDC Vaccine Manufacturing Initiative
Getting in
The routes into the role and what each one asks for.
What to study
8 courses- Diploma in Human BiosciencesKsh 34,920a year
- Certificate in Health Services SupportKsh 50,500a year
- Certificate in HIV/AIDS ManagementKsh 63,290a year
- Artisan in Community HealthKsh 67,189a year
- Certificate in Health Records and ITKsh 67,189a year
- Certificate in Science Laboratory TechnicianKsh 67,189a year
- Certificate in Science Laboratory TechnologyKsh 67,189a year
- Craft in School Laboratory TechnicianKsh 67,189a year
How people get in
Biotechnology/Pharmacy degree + vaccine manufacturing specialisation
4 years + 1 yearMedium cost
Standard biotechnology or pharmacy degree route, adding vaccine-specific production and quality control training.
Pharmaceutical manufacturing technician transition
1 yearLow cost
Experienced pharmaceutical manufacturing staff add vaccine-specific process and cold-chain knowledge.
Certifications
GMP Certification
International pharmaceutical training bodiesKsh 70,0002 months
Tools of the trade
Laboratory Information Management System (LIMS)
Quality SystemsRequiredPaid
Interview preparation
2 questionsWhy is cold-chain management particularly critical for mRNA vaccine production compared to other vaccine types?
TechnicalMid
Look for understanding that mRNA molecules are especially temperature-sensitive and degrade quickly outside strict cold-chain conditions, unlike some more stable traditional vaccine formulations.
A quality control test shows results just outside the acceptable range. What do you do?
SituationalSenior
Should describe following strict protocol: documenting the deviation, escalating per GMP procedures, and never overriding quality standards for production timeline pressure.
Common misconceptions
Africa already has widespread mRNA vaccine manufacturing capacity.
Capacity remains concentrated in a small number of facilities across the continent — genuinely growing but still early-stage relative to global production hubs.
This work is only relevant during pandemic emergencies.
Routine vaccine manufacturing for established immunisation programmes (measles, polio, etc.) is ongoing, continuous work, not just crisis-driven production.
What happens next
How the role changes from here, and where it leads.
The near term
Growing steadily as African vaccine manufacturing self-sufficiency remains a continental priority
- Africa CDC continuing to fund regional manufacturing capacity build-out
- Growing local biotech talent pipeline ahead of capacity expansion
- What to do
- Build strong GMP quality systems knowledge alongside biotechnology fundamentals — regulatory compliance rigor is as important as the science itself in this field.
Where pay is heading
2024 to 2030Monthly pay in Kenyan shillings, rounded to the nearest thousand. These are projections, not observations.
Growth outlook
- Net demand change
- 20
- Over
- 2025-2028
- Drivers
- Africa CDC continental vaccine manufacturing initiative,Post-COVID push for regional vaccine self-sufficiency
- Headwinds
- Capacity investment remains concentrated in a small number of facilities
Supply and demand
- Demand
- 20
- Supply pressure
- 20
- Balance
- Balanced
What to learn
- Vaccine production process technology
- GMP (Good Manufacturing Practice) quality systems
- Cold-chain logistics management
Where people move next
2 recorded movesLine length under each name is the distance of the move: shorter means more of what you already do carries over. Marked lines are steps up rather than sideways.
- Biotechnology Researcher
Easy60% skill overlapLateral
Broader biotechnology research role beyond vaccine manufacturing specifically.
- Clinical Pharmacist
Moderate40% skill overlapLateral
Related pharmaceutical role, more patient-facing than manufacturing-focused.
Related careers
Kenyan market notes
African vaccine manufacturing capacity remains concentrated in a small number of facilities regionally, but continental initiatives are building genuine momentum and local biotech/pharma talent is being developed ahead of expected capacity growth.
Further reading
This role is rated 28 out of 100 today. Save it and the app keeps that number, then tells you by how much it has moved when the record is next reviewed.